Welcome
Login

Post vaccine deaths

Featured

Thanks! Share it with your friends!

URL

You disliked this video. Thanks for the feedback!

Sorry, only registred users can create playlists.
URL


Added by COVID in Coronavirus in USA
4 Views

Coronavirus: Description video

Watch the video “Post vaccine deaths” and like it!

Correction

58-year old immunocompetent male

Immunocompromised

Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report

https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab129/6132402

Antibody-dependent enhancement
Also

Convergent evolution

Coevolution

htttps://vaers.hhs.gov

https://vaers.hhs.gov/reportevent.html

December 14, 2020, to February 7, 2021

Over 41 million doses of COVID-19 vaccines administered in the United States

VAERS received 1,170 reports of death (0.003%) among people who received a COVID-19 vaccine

CDC and FDA physicians review each case report of death as soon as notified

CDC requests medical records to further assess reports

A review of available clinical information

Death certificates

Autopsy reports

Medical records

Revealed no link with vaccination

CDC and FDA will continue to investigate reports of adverse events, including deaths, reported to VAERS.

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html

COVID-19 vaccines are safe and effective.

Millions of people in the United States have received COVID-19 vaccines, and these vaccines will undergo the most intensive safety monitoring in U.S. history.

CDC recommends you get a COVID-19 vaccine as soon as you are eligible.

CDC, FDA, and other federal partners will continue to monitor the safety of the COVID-19 vaccines

Coronavirus vaccine – weekly summary of yellow card reporting

https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting#analysis-of-data

Vaccination is the single most effective way to reduce deaths and severe illness from COVID-19.

The number and nature of suspected adverse reactions reported so far are not unusual in comparison to other types of routinely used vaccines

The overall safety experience with both vaccines is so far as expected from the clinical trials

Based on current experience, the expected benefits of both COVID-19 vaccines in preventing COVID-19 and its serious complications far outweigh any known side effects

As with all vaccines and medicines, the safety of COVID-19 vaccines is being continuously monitored

Events with a fatal outcome

Based on age-stratified all-cause mortality in England and Wales

Several thousand deaths are expected to have occurred,

naturally,

within 7 days

of the many millions of doses of vaccines administered so far

MHRA

Pfizer/BioNTech

143 UK reports, patient died shortly after vaccination

Oxford University/AstraZeneca

90 reports of deaths

Majority in elderly, underlying illness

Review of individual reports, does not suggest the vaccine played a role in the death

Australia vaccination

Scott Morrison, 80,000 people a week from the end of February

Greg Hunt, 1 million doses a week from the end of March

Population, 26 million

Pfizer approved last month

Allowed to leave Europe

20 million doses

142,000 doses landed on Monday, starting next Monday, 22nd February

Border Force officers, hotel quarantine workers, Aged Care residents and workers

https://www.abc.net.au/news/2021-02-16/coronavirus-astrazeneca-vaccine-approved-for-use-in-australia/13115784

Approved Oxford AstraZeneca

Secured 53.8 million doses

Produced in Melbourne (50 million)

Vaccine most Australians will get

Therapeutic Goods Administration (TGA)

Approved for use over 18 years

People over the age of 65 demonstrated a strong immune response

Over 65s, case-by-case basis

No upper age limit

Two does, 12 weeks apart, minimum 4 weeks

Five priority groups

https://www.abc.net.au/news/2021-02-05/when-will-you-get-the-covid-19-vaccine/13112610

Green passports

Liked the “Post vaccine deaths” video?

Share it with your friends!

Post your comment

Comments

Be the first to comment
RSS